Studies how genes, diet and gut microbes relate to digestive conditions
Studies how diet, genes and gut bacteria affect digestive conditions in adults.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Enabling Microbiomics- Driven Personalized Nutrition
- Status
- Enrolling by invitation
- People taking part
- 4,001 people, planned
- Started
- 28 Mar 2025
- Expected to end
- Apr 2028
- Type of study
- Observational
- Record updated
- 12 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with gut conditions such as IBD, IBS, Crohn's disease, celiac disease, diarrhea or constipation. It also takes healthy adults without gut disease as controls.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Gastrointestinal patients in these groups: Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Crohn's Disease, Celiac Disease, Diarrhea, Constipation. Healthy controls have no gastrointestinal disease or symptoms at the time of sampling.
- Biomarker or test result
- Genomic sequencing results may be available, but are not required.
Main reasons for not taking part
- Cognitive impairment
- Active use of antibiotics at the time of stool collection
- No smartphone with internet access
- Cannot give written, informed consent
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age greater than or equal to 18 years
- Gastrointestinal patients with or without genomic sequencing results available for the following cohorts:; Inflammatory Bowel Disease (IBD); Irritable Bowel Syndrome (IBS); Crohn's Disease; Celiac Disease; Diarrhea; Constipation
- Healthy age and sex matched controls with or without genomic sequencing results available; o Control is defined as patients without gastrointestinal disease or no symptoms at time of sampling
- Able to provide written, informed consent
- Participant has a smartphone device with access to internet connection
Who cannot take part
- Patients with cognitive impairment
- Active use of antibiotics at the time of stool collection
Where in United States
- Mayo ClinicRochester, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The goal of this observational research study is to determine how diet contributes to various gastrointestinal related conditions.
Read full original descriptionShow less
The main question investigators aim to answer is:
Are host genetics, diet, and microbiome all important determinants of GI disorders, and how their relative contribution varies among individuals and populations.
The group in the trial
- GI Disorders
Inflammatory Bowel Disease, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease, Diarrhea, Constipation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Enabling Microbiomics- Driven Personalized Nutrition (EMPOWER)
- Plain-language title
- Studies how genes, diet and gut microbes relate to digestive conditionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 June 2026